Which has the lower trailing P/E, ABBV or MRK?

ABBV has the lower trailing P/E: ABBV trades at 72.43 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or MRK?

Over the past five years, MRK grew revenue faster — ABBV at a 3.69% CAGR versus MRK at 7.87%.

Does ABBV or MRK pay a bigger dividend?

ABBV yields 2.68% and MRK yields 2.32% based on trailing dividends and the latest price.

Is ABBV or MRK more profitable?

ABBV runs the higher net margin — ABBV at 9.81% versus MRK at 4.78%.

How have ABBV and MRK total returns compared?

Over the past 10 years, ABBV delivered 19.76% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Merck & Co., Inc. (MRK)

A side-by-side comparison of AbbVie Inc. and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

MRK

Merck & Co., Inc.

$355.49B

$143.94HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABBV vs MRK

growth of $100 · dividends reinvested · last 10y

ABBV +507.0% (+19.8%/yr)MRK +226.1% (+12.5%/yr)ABBV compounded faster over this window

ABBV MRK

ABBV vs MRK: by the numbers

•ABBV is the larger company ($454.17B vs $355.49B market cap).
•ABBV trades at the lower trailing earnings multiple (72.43 vs 115.15 P/E), one valuation lens rather than an overall verdict.
•ABBV converts more revenue to profit (9.81% vs 4.78% net margin).
•MRK grew revenue faster over the past five years (7.87% vs 3.69% CAGR).
•ABBV pays the higher dividend yield (2.68% vs 2.32%).

Metrics side by side

Valuation

Metric	ABBV	MRK
P/E ratio	72.43	115.15
Forward P/E	18.32	52.41
P/S ratio	7.05	5.35
P/B ratio	N/A	8.48
EV / EBITDA	19.34	22.76
FCF yield	3.99%	4.52%

Profitability

Metric	ABBV	MRK
Gross margin	71.48%	75.38%
Operating margin	29.32%	36.17%
Net margin	9.81%	4.78%
ROE	N/A	7.57%
ROIC	13.46%	5.80%

Dividends

Metric	ABBV	MRK
Dividend yield	2.68%	2.32%
Payout ratio	192.43%	268.80%

Growth (annualized)

Metric	ABBV	MRK
Revenue CAGR (5Y)	3.69%	7.87%
EPS CAGR (5Y)	-2.79%	21.21%
FCF CAGR (5Y)	0.11%	23.61%
Total return CAGR (5Y)	23.51%	18.15%

Frequently asked

Which has the lower trailing P/E, ABBV or MRK?: ABBV has the lower trailing P/E: ABBV trades at 72.43 and MRK at 115.15. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or MRK?: Over the past five years, MRK grew revenue faster — ABBV at a 3.69% CAGR versus MRK at 7.87%.
Does ABBV or MRK pay a bigger dividend?: ABBV yields 2.68% and MRK yields 2.32% based on trailing dividends and the latest price.
Is ABBV or MRK more profitable?: ABBV runs the higher net margin — ABBV at 9.81% versus MRK at 4.78%.
How have ABBV and MRK total returns compared?: Over the past 10 years, ABBV delivered 19.76% and MRK delivered 12.68% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full MRK analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Merck P/E ratio AbbVie dividend yield Merck dividend yield AbbVie ROE Merck ROE AbbVie operating margin Merck operating margin AbbVie revenue growth Merck revenue growth AbbVie free cash flow Merck free cash flow

AbbVie & Merck appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.